Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LIFECORE BIOMEDICAL, INC. \DE\ Director's Dealing 2016

May 31, 2016

33431_dirs_2016-05-31_729bb5d1-934a-4f8d-adb2-0e3595c83c84.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2016-05-26

Reporting Person: HIEBERT LARRY D (Executive Vice President)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-26 Incentive Stock Option (Right to Buy) $11.49 M 15000 Acquired 2023-05-26 Common Stock (15000) Direct
2016-05-26 Right to Buy Restricted Stock Unit (RSU) $ M 5000 Acquired Common Stock (5000) Direct

Footnotes

F1: Restricted Stock Units will vest on the 3rd anniversary of the grant date and will be automatically settled in shares of common stock.

F2: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.